NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»23/12/2009 [Company watch]
Hard to Treat Diseases to sell MindUp BioResearch division to Chinese herbal company

Hard to Treat Diseases, Inc. (HTDS), a US-based provider of immunostimulant for combating cancer and rheumatoid arthritis under medical patent, has agreed to sell its Serbia-based MindUp BioResearch division to a herbal medicine company in China.

 

Hard to Treat Diseases, Inc. (HTDS), a US-based provider of immunostimulant for combating cancer and rheumatoid arthritis under medical patent, has agreed to sell its Serbia-based MindUp BioResearch division to a herbal medicine company in China.

MindUp BioResearch is a developer of new therapeutics to overcome the cancer cell resistance in chemotherapy and also conducts research on identification of genes connected with lung cancer.

The acquirer focuses on production and manufacturing of premium herbs, herbal extracts and herbal preparations.

The transaction is expected to close on or before December 31, 2009.


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.